Suppr超能文献

TRIM8在p53野生型背景下减弱ΔNp63α的促增殖作用。

TRIM8 Blunts the Pro-proliferative Action of ΔNp63α in a p53 Wild-Type Background.

作者信息

Caratozzolo Mariano Francesco, Marzano Flaviana, Abbrescia Daniela Isabel, Mastropasqua Francesca, Petruzzella Vittoria, Calabrò Viola, Pesole Graziano, Sbisà Elisabetta, Guerrini Luisa, Tullo Apollonia

机构信息

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council (CNR), Bari, Italy.

Institute for Biomedical Technologies, National Research Council (CNR), Bari, Italy.

出版信息

Front Oncol. 2019 Nov 5;9:1154. doi: 10.3389/fonc.2019.01154. eCollection 2019.

Abstract

The p53 gene family network plays a pivotal role in the control of many biological processes and therefore the right balance between the pro-apoptotic and pro-survival isoforms is key to maintain cellular homeostasis. The stability of the p53 tumor suppressor protein and that of oncogenic ΔNp63α, is crucial to control cell proliferation. The aberrant expression of p53 tumor suppressor protein and oncogenic ΔNp63α contributes to tumorigenesis and significantly affects anticancer drug response. Recently, we demonstrated that TRIM8 increases p53 stability, potentiating its tumor suppressor activity. In this paper, we show that TRIM8 simultaneously reduces the level of the pro-proliferative ΔNp63α protein, in both a proteasomal and caspase-1 dependent way, thereby playing a critical role in the cellular response to DNA damaging agents. Moreover, we provided evidence that ΔNp63α in turn, suppresses TRIM8 gene expression by preventing p53-mediated transactivation of TRIM8, therefore suggesting the existence of a negative feedback loop. These findings indicate that TRIM8 exerts its anticancer power through a joint action that provides on one hand, the activation of the p53 tumor suppressor role, and on the other the quenching of the oncogenic ΔNp63α protein activity. The enhancement of TRIM8 activity may offer therapeutic benefits and improve the management of chemoresistant tumors.

摘要

p53基因家族网络在许多生物过程的调控中起着关键作用,因此促凋亡和促生存异构体之间的适当平衡是维持细胞稳态的关键。p53肿瘤抑制蛋白和致癌性ΔNp63α的稳定性对于控制细胞增殖至关重要。p53肿瘤抑制蛋白和致癌性ΔNp63α的异常表达会导致肿瘤发生,并显著影响抗癌药物反应。最近,我们证明TRIM8可增加p53的稳定性,增强其肿瘤抑制活性。在本文中,我们表明TRIM8同时以蛋白酶体和caspase-1依赖的方式降低促增殖性ΔNp63α蛋白的水平,从而在细胞对DNA损伤剂的反应中起关键作用。此外,我们提供的证据表明,ΔNp63α反过来通过阻止p53介导的TRIM8反式激活来抑制TRIM8基因表达,因此提示存在负反馈环。这些发现表明,TRIM8通过联合作用发挥其抗癌作用,一方面激活p53的肿瘤抑制作用,另一方面抑制致癌性ΔNp63α蛋白活性。增强TRIM8活性可能具有治疗益处,并改善对化疗耐药肿瘤的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17c4/6856647/929c5f504410/fonc-09-01154-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验